MLchartDataset catalogue

Romvimza

Term · Oncology and biomedicine · MLC-T-ONC-007492

A drug used to treat adults with tenosynovial giant cell tumor, a rare, usually benign (not cancer) tumor that affects the joints. It is used when surgery may make the symptoms worse or cause severe problems. It is also being studied in the treatment of other conditions related to cancer. Romvimza blocks certain proteins, which may help keep tumor cells from growing and spreading. It is a type of tyrosine kinase inhibitor. Also called vimseltinib dihydrate.

Table 1. Record
IdentifierMLC-T-ONC-007492
FieldOncology and biomedicine
Synonymsvimseltinib dihydrate
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-007492",
  "term": "Romvimza",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with tenosynovial giant cell tumor, a rare, usually benign (not cancer) tumor that affects the joints. It is used when surgery may make the symptoms worse or cause severe problems. It is also being studied in the treatment of other conditions related to cancer. Romvimza blocks certain proteins, which may help keep tumor cells from growing and spreading. It is a type of tyrosine kinase inhibitor. Also called vimseltinib dihydrate.",
  "synonyms": [
    "vimseltinib dihydrate"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/romvimza/"
}

Record 14,561 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.